Abstract
BackgroundSystemic lupus erythematosus (SLE) is a complex and potentially severe autoimmune disease. Belimumab is the latest drug, and the first biologic compound, that was registered for treatment of SLE. There...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have